METR-NK cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for METR-NK cells, covering 2024-05-02 to 2024-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]